Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity
Journal of Drugs in Dermatology · 01.03.2026 · 25 (3) · 268-272
DOI: 10.36849/jdd.9677 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.02.2026. Verfasst von Alan D Widgerow. Hauptthemen laut MEDLINE: Skin Aging, Cellular Senescence, Skin. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Widgerow, A. D. (2026). Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity. Journal of Drugs in Dermatology, 25(3), 268-272. https://doi.org/10.36849/jdd.9677
Vancouver
Widgerow AD. Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity. Journal of Drugs in Dermatology. 2026;25(3):268-272. doi:10.36849/jdd.9677
BibTeX
@article{Widgerow2026,
author = {Widgerow, Alan D},
title = {Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {3},
pages = {268--272},
doi = {10.36849/jdd.9677}
}
EUVIMED